How is Ameluz used to treat actinic keratosis?
Medically reviewed by Drugs.com Last updated on Apr 11, 2019.
Official Answerby Drugs.com
Ameluz gel is applied to the lesions on your skin by your doctor, and then covered with a light blocking, occlusive dressing for three hours. After that time the gel is removed, and the area is illuminated with BF-RhodoLED red light. Ameluz increases photosensitivity, an immune system reaction that is triggered by sunlight. Therefore, patients should avoid exposure to sunlight, prolonged or intense light (such as tanning beds, sun lamps) for 48 hours following treatment.
Ameluz (generic name: BF-200 ALA) is Biofrontera’s topical prescription drug used with BF-RhodoLED photodynamic therapy (PDT) for treatment of mild to moderate actinic keratosis on the face and scalp. An Actinic keratosis is a rough, scaly area of the skin due to years of sun exposure. Actinic keratosis, if left untreated, can develop into squamous cell carcinoma, a potentially fatal skin disease with rapidly growing incidence.
Ameluz is already approved and marketed in Europe and U.S. launch is expected in September 2016.
- Ameluz Information for Consumers
- Ameluz Information for Healthcare Professionals (includes dosage details)
- Side Effects of Ameluz (detailed)